Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter.
about
Imaging multiple sclerosis and other neurodegenerative diseasesNew magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.Imaging assessment of traumatic brain injury.Correlation between white matter damage and gray matter lesions in multiple sclerosis patients.Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.Examination of cognitive fatigue in multiple sclerosis using functional magnetic resonance imaging and diffusion tensor imagingIncreased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.Evaluation of the Degradation of the Selected Projectile, Commissural and Association White Matter Tracts Within Normal Appearing White Matter in Patients with Multiple Sclerosis Using Diffusion Tensor MR Imaging - a Preliminary Study.Structural Brain Network Characteristics Can Differentiate CIS from Early RRMSGray Matter Involvement in Radiologically Isolated Syndrome.Normal-appearing brain tissue analysis in radiologically isolated syndrome using 3 T MRI.Gray Matter Atrophy Is Primarily Related to Demyelination of Lesions in Multiple Sclerosis: A Diffusion Tensor Imaging MRI Study.Very early MS--insights from MRI.Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.The prognostic utility of MRI in clinically isolated syndrome: a literature review.Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.Functional connectivity changes and their relationship with clinical disability and white matter integrity in patients with relapsing-remitting multiple sclerosis.Diffusion Tensor Imaging in NAWM and NADGM in MS and CIS: Association with Candidate Biomarkers in SeraResting state networks change in clinically isolated syndrome.Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.Atlas-based versus individual-based fiber tracking of the corpus callosum in patients with multiple sclerosis: reliability and clinical correlations.Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.Early white matter changes in childhood multiple sclerosis: a diffusion tensor imaging study.Clinical impact of early brain atrophy in clinically isolated syndromesDifferential Gray Matter Vulnerability in the 1 Year Following a Clinically Isolated Syndrome
P2860
Q26826889-827332AF-C46C-4D67-BDD5-62D22B8F9CF2Q30597559-61F9C862-6E1B-4BB4-A257-F9E387EB1789Q31029511-5FC1EF3C-4890-404E-A325-50FE73BC177AQ33771276-61E1995B-E036-4C09-9E6A-38972EE071ABQ34303664-84627DE2-B751-4013-A266-D1B94F3E0F2BQ34733726-7D7E866C-1EB6-4A4C-B6D4-A4245A3D4D4EQ35041040-577DC3E4-AF1D-460E-9283-319C2F4D924AQ35182294-BE784EEE-FDB4-425E-A30E-CFC1963270F2Q35760156-B0EC5D8F-38CE-4422-BACB-CAAC1BB53C5BQ36155754-8331C445-96BB-442F-BC53-45488162A747Q36527375-8DE124D1-8796-45C9-BBC6-F4766179F15FQ37205897-183AAFED-F68E-48DA-BF6D-21F5AEBFC723Q37328066-7450B243-B6E9-4E2A-990E-46E35CA23109Q37729520-57F1EF00-1BFB-489B-B6A0-2D3C56659AB3Q38023710-9916FC18-9191-4B80-987F-1ABCDF5501DFQ38029255-9082BDD3-9023-426C-AF6F-9FF627A28DAFQ38211996-CA3DA769-A2AF-46DE-AA49-DC1FC4731DDAQ39091396-D508EB17-3F39-4344-8411-E069C5BE109AQ39902923-2EB0690F-84F6-428C-91C3-F9ECC8E95A5BQ40871046-1BD677D2-48A7-49C7-8BE1-BFB26A0CD88EQ41771263-F235E355-1D30-445F-A537-79B2CE64B4CBQ43587438-6760DDB9-5DFB-417E-A6F2-CD99643D558CQ44486220-4F8B4223-A6A3-4C72-8A6D-657E25285192Q45499382-74011A45-1D0B-4AF4-85EB-34AF8E42012BQ47908989-D3CF739E-3819-456B-B303-1A0BF99A533AQ49089264-716F8004-B1D1-4422-9153-42DFD3D2D2C1Q50744084-01B28ED4-3D84-4BAB-8809-B43E45CBD968Q57601852-2DA57F70-C087-484C-AAE6-C5D654711885Q58573193-7875CA98-BE1E-46EA-AE68-8A5B5BEF7E51
P2860
Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinically isolated syndrome s ...... tion of white and gray matter.
@ast
Clinically isolated syndrome s ...... tion of white and gray matter.
@en
Clinically isolated syndrome s ...... tion of white and gray matter.
@nl
type
label
Clinically isolated syndrome s ...... tion of white and gray matter.
@ast
Clinically isolated syndrome s ...... tion of white and gray matter.
@en
Clinically isolated syndrome s ...... tion of white and gray matter.
@nl
prefLabel
Clinically isolated syndrome s ...... tion of white and gray matter.
@ast
Clinically isolated syndrome s ...... tion of white and gray matter.
@en
Clinically isolated syndrome s ...... tion of white and gray matter.
@nl
P2093
P1433
P1476
Clinically isolated syndrome s ...... tion of white and gray matter.
@en
P2093
Carlo Pozzilli
Emilia Sbardella
Mara Cercignani
Patrizia Pantano
Porzia Totaro
P304
P356
10.1148/RADIOL.2541090817
P407
P577
2009-12-17T00:00:00Z